Ecaterina Rînja

Dr. Ecaterina Rînja

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2023 in Gut
Verified
Journal Article
Open access
PDF file
CAChristoph Ammer-Herrmenau
Christoph Ammer-Herrmenau
KAKai L Antweiler
Kai L Antweiler
TAThomas Asendorf
Thomas Asendorf
GBGeorg Beyer
Georg Beyer
SBSoeren M Buchholz
Soeren M Buchholz
Albrecht NeesseAlbrecht Neesse
Albrecht Neesse
Objective Early disease prediction is challenging in acute pancreatitis (AP). Here, we prospectively investigate whether the microbiome predicts severity of AP (Pancreatitis—Microbiome As Predictor of Severity; P-MAPS) early at hospital admission. Design Buccal and rectal microbial swabs were collected from 424 patients with AP within 72 hours of hospital admission in 15 European centres. All samples were sequenced by full-length 16S rRNA and metagenomic sequencing using Oxford Nanopore Technologies. Primary endpoint was the association of the orointestinal microbiome with the revised Atlanta classification (RAC). Secondary endpoints were mortality, length of hospital stay and severity (organ failure >48 hours and/or occurrence of pancreatic collections requiring intervention) as post hoc analysis. Multivariate analysis was conducted from normalised microbial and corresponding clinical data to build classifiers for predicting severity. For functional profiling, gene set enrichment analysis (GSEA) was performed and normalised enrichment scores calculated. Results After data processing, 411 buccal and 391 rectal samples were analysed. The intestinal microbiome significantly differed for the RAC (Bray-Curtis, p value=0.009), mortality (Bray-Curtis, p value 0.006), length of hospital stay (Bray-Curtis, p=0.009) and severity (Bray-Curtis, p value=0.008). A classifier for severity with 16 different species and systemic inflammatory response syndrome achieved an area under the receiving operating characteristic (AUROC) of 85%, a positive predictive value of 67% and a negative predictive value of 94% outperforming established severity scores. GSEA revealed functional pathway units suggesting elevated short-chain fatty acid (SCFA) production in severe AP. Conclusions The orointestinal microbiome predicts clinical hallmark features of AP, and SCFAs may be used for future diagnostic and therapeutic concepts. Trial registration number NCT04777812.

10 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
MIMadalina Ilie
Madalina Ilie
VSVasile Sandru
Vasile Sandru
CGCONSTANTINESCU R GABRIEL
CONSTANTINESCU R GABRIEL
OPOana Mihaela Plotogea
Oana Mihaela Plotogea
EREcaterina Rînja
Ecaterina Rînja
BBBogdan Valeriu Bogdan
Bogdan Valeriu Bogdan
Artificial intelligence (AI) is a term that covers a multitude of techniques that are used in a manner that tries to reproduce human intelligence. AI is helpful in various medical specialties that use imaging for diagnostic purposes, and gastroenterology is no exception. In this field, AI has several applications, such as detecting and classifying polyps, detecting the malignancy in polyps, diagnosing Helicobacter pylori infection, gastritis, inflammatory bowel disease, gastric cancer, esophageal neoplasia, and pancreatic and hepatic lesions. The aim of this mini-review is to analyze the currently available studies regarding AI in the field of gastroenterology and hepatology and to discuss its main applications as well as its main limitations.

7 March 2022 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
ACAlexandru Constantinescu
Alexandru Constantinescu
OPOana Mihaela Plotogea
Oana Mihaela Plotogea
MSMădălina Stan‐Ilie
Mădălina Stan‐Ilie
TCTudorel Ciurea
Tudorel Ciurea
DGDan Ionut Gheonea
Dan Ionut Gheonea
GCGabriel Constantinescu
Gabriel Constantinescu

26 July 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
VSVasile Sandru
Vasile Sandru
Bogdan Silviu UngureanuBogdan Silviu Ungureanu
Bogdan Silviu Ungureanu
MIMadalina Ilie
Madalina Ilie
RORuxandra Oprita
Ruxandra Oprita
GBGheorghe Balan
Gheorghe Balan
CGCONSTANTINESCU R GABRIEL
CONSTANTINESCU R GABRIEL
Background: Cholangiocarcinoma is the most common malignancy of the bile ducts causing intrahepatic, hilar, or distal bile duct obstruction. Most jaundiced patients are diagnosed with unresectable tumors in need for palliative bile duct drainage and chemotherapy. Endobiliary radiofrequency ablation (RFA) is an adjuvant technique that may be applied prior to biliary stenting. The aim of our study was to assess the efficacy of endobiliary RFA prior to stent insertion in patients with unresectable distal cholangiocarcinomas. Methods: Twenty-five patients (eight treated with RFA and stenting and 17 treated with stenting alone) were included in a case-controlled study. We prospectively assessed the impact of RFA on the survival rate, the patient performance status, and the preservation of eligibility for chemotherapy based on the patient laboratory profile. Results: Patients treated with RFA prior to stenting proved to have a significantly longer survival interval (19 vs. 16 months, p = 0.04, 95% CI) and significantly better performance status. Moreover, the laboratory profiles of patients treated with RFA has been proven superior in terms of total bilirubin, liver enzymes, and kidney function, thus making patients likely eligible for palliative chemotherapy. Post-ERCP adverse events were scarce in both the study group and the control group. Conclusion: Given the isolated adverse events and the impact on the patient survival, performance, and laboratory profile, RFA can be considered safe and efficient in the management of patients with unresectable distal cholangiocarcinomas.

24 February 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
RCRoxana-Luiza Caragut
Roxana-Luiza Caragut
MIMadalina Ilie
Madalina Ilie
TCTeodor Cabel
Teodor Cabel
DGDeniz Gunsahin
Deniz Gunsahin
APAfrodita Panaitescu
Afrodita Panaitescu
VSVasile Sandru
Vasile Sandru
Cholangiocarcinoma (CCA) is an adenocarcinoma originating from the epithelial cells of the bile ducts/hepatocytes or peribiliary glands. There are three types of cholangiocarcinoma: intrahepatic, perihilar and distal. CCA represents approximately 3% of the gastrointestinal malignancies. The incidence of CCA is higher in regions of the Eastern world compared to the Western countries. There are multiple risk factors associated with cholangiocarcinoma such as liver fluke, primary sclerosing cholangitis, chronic hepatitis B, liver cirrhosis and non-alcoholic fatty liver disease. Endoscopy plays an important role in the diagnosis and management of cholangiocarcinoma. The main endoscopic methods used for diagnosis, biliary drainage and delivering intrabiliary local therapies are endoscopic retrograde cholangiopancreatography and endoscopic ultrasound. The purpose of this review is to analyze the current data found in literature about cholangiocarcinoma, with a focus on the actual diagnostic tools and endoscopic management options.

19 September 2021 in Gastroenterology Insights
Verified
Journal Article
Open access
PDF file
MIMadalina Ilie
Madalina Ilie
OPOana Mihaela Plotogea
Oana Mihaela Plotogea
EREcaterina Rînja
Ecaterina Rînja
VSVasile Sandru
Vasile Sandru
ABAndreea Butuc
Andreea Butuc
CGCONSTANTINESCU R GABRIEL
CONSTANTINESCU R GABRIEL
Introduction. Ultrasound-guided (US-guided) percutaneous drainage (PD) of abdominal collections represents the first-choice alternative to surgical intervention. The aim of our study was to assess the efficacy and safety of PD of visceral and non-visceral abdominal collections by reviewing our personal experience over a period of 5 years. Material and methods. The present study included 66 patients who underwent PD under ultrasound guidance. We analyzed clinical variables (collection size, catheter diameter, collection type, microbiological analysis, antibiotic regimens) along with the outcomes of the procedure. Results. Visceral collections were predominant, encompassing 38 hepatic abscesses and 1 splenic hematoma. Microbiological analysis showed that the majority (54%) were monomicrobial. The most encountered pathogens were Klebsiella pneumoniae and Escherichia coli. Technical success was achieved in all cases and clinical success was observed in 84.6% of the cases. No immediate procedural complications were detected. There were 6 patients who needed reinterventions, either by catheter replacement or by surgical treatment. The mortality rate was 4.5%, due to patients’ poor overall status and oncological comorbidities. Conclusions. Percutaneous drainage under ultrasound guidance is a safe and effective procedure in the management of abdominal collections.